Iannis Aifantis, Chairman of the Department of Pathology at NYU School of Medicine, shared a post on LinkedIn:
“After almost 13 years I am stepping down from the helm of the Department of Pathology at NYU Grossman School of Medicine.
It was a privilege and a pleasure to contribute to the creation of one of the most exciting Pathology Departments in the US and to work with fantastic colleagues, pathologists, research scientists, staff and trainees.
During this exciting period, our department almost tripled its faculty numbers, clinical and research (grant $$) revenue and invested heavily in a state-of-the-art molecular pathology lab, the growth of molecular microbiology, the expansion and automation of our clinical labs, and the integration of new digital and artificial intelligence tools that are redefining how our pathologists diagnose disease.
We are now one of the few Path departments with ~100% slide digitization and a fully digital sign out. The department’s research profile has increased significantly with the recruitment of leaders in the areas of immunology, cancer biology, computational science as well as world-renowned pathologists and physician-scientists. On a personal level, I was blessed to be thrown in deep water early in my career and bet on the talent and brilliance of my colleagues who helped me set the foundation for a truly integrated and 21st century Pathology Department.
I remain here to aid the transition of leadership, excited to spend more time in my own research lab and soon take up new challenges.”
Other articles on OncoDaily.